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Background: Early psychosocial interventions targeting cognitive and functional outcomes
in individuals at clinical high risk for psychosis are a research priority. An even greater need is
the identification of effective interventions in underserved populations. Compensatory
Cognitive Training (CCT) is a psychosocial intervention with demonstrated efficacy in
chronic schizophrenia and first episode psychosis, but remains to be evaluated in pre-
illness phases. The aim of this study was to describe the development and implementation
of an ongoing pilot randomized controlled trial investigating the efficacy of group-based,
manualized CCT, as compared to recreational therapy (RT), for Latino participants at clinical
high risk for psychosis (CHR) in both the United States and Mexico. It is hypothesized that,
in comparison to those receiving RT, participants receiving CCT will show significant
improvements in neurocognitive performance and functional capacity (co-primary
outcomes) and self-rated functioning and clinical symptoms (secondary outcomes).
Methods: Latino CHR participants aged 12–30 years will be included in the study. Both
CCT and RT will be delivered in either Spanish or English, depending on group preference.
Additionally, all assessments will be administered in participants’ preferred language. A
comprehensive assessment of neurocognitive and functional performance and clinical
symptomatology will be performed at baseline, mid-intervention (4 weeks, 8 weeks), post-
intervention (12 weeks) and 3-month follow-up. The primary outcome measures are
neurocognition and functional capacity, as assessed by the MATRICS (Measurement and
Treatment Research in Cognition in Schizophrenia) Consensus Cognitive Battery and the
University of California, San Diego Performance-Based Skills Assessment-Brief,
respectively. Furthermore, secondary outcomes measures will be used to examine
change in clinical symptoms and self-reported functioning in response to CCT versus RT.g January 2020 | Volume 10 | Article 9511
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Frontiers in Psychiatry | www.frontiersin.orDiscussion: The evaluation of a novel treatment such as CCT in CHR youth will provide
empirical support for a low risk, comprehensive cognitive intervention that could have
important implications for public health if it improves neurocognition and functioning.Keywords: cognition, attention, memory, executive functioning, rehabilitation, schizophreniaINTRODUCTION
Recent efforts to extend medical prevention models to the field of
schizophrenia have resulted in systematic, reliable identification
of individuals who are at clinical high risk (CHR) for imminent
onset of psychosis (i.e., putative prodromal psychosis) (1, 2).
Compared to psychotic disorders, the symptoms of psychosis-
risk syndrome are less severe and more transient. Symptoms are
not longstanding trait-pathology, but rather present as a marked
change in individual’s mental state, evidenced through report
from self and concerned others. Specific subtypes of the
psychosis-risk syndrome are identified through formal
structured clinical interview and are differentiated through
individual risk factors. Broadly, risk factors for psychosis-risk
syndrome include presence of: attenuated positive symptoms,
negative symptoms, cognitive impairment or cognitive decline,
decline in social, and/or role functioning, as well as family history
of psychosis (3, 4). Diagnosis of a psychosis-risk syndrome
requires that symptoms are associated with functional
impairment and/or distress and of recent onset or worsening.
Findings from the North American Prodrome Longitudinal
Study (NAPLS) have established that within the first 1–2 years
after formal identification of being at CHR for psychosis, 20–40%
of individuals go on to develop an acute psychotic illness (3, 5, 6).
Despite advances in the early identification of individuals
meeting CHR criteria, there is significant need for effective
interventions that can be implemented early in the course of
illness to improve symptoms and functional outcomes, especially
considering that the strongest predictors of conversion to
psychotic illness include modifiable risk factors such as
prodromal symptom severity (as measured through structured
interview), declines in social functioning, as well as verbal
learning and memory deficits (6). Namely, there is a need for
interventions that target the emerging neurocognitive (7–9),
information processing (10–12), social, role, and global
functioning deficits (13, 14) that characterize the prodromal
period of illness. Not only are these early deficits disruptive to
normal development and life trajectories, but they are also
predictive of later conversion to psychotic illness (6, 15).
Antipsychotic medication, although effective in controlling
positive symptoms, does not ameliorate cognitive deficits (16),
nor has it shown any effects on conversion in randomized clinical
trials (17, 18). Moreover, ethical concerns regarding exposing
young people to psychotropic agents when less than half (~35%)
are expected to convert to psychosis (19, 20) further support
“staging” the prodromal period much like other medical illnesses
(e.g., cancer, diabetes) and using less invasive treatments
(psychosocial, education) for the early stages. Neurocognitive
deficits are present across all identified stages of the CHR stateg 2and remain relatively stable, even during symptomatic remission
upon illness onset (21). As such, an individualized, low risk
treatment algorithm that focuses on neurocognition and
functioning, in addition to the presenting subsyndromal
psychotic symptoms, is a logical intervention strategy for this
phase of the illness.
To date, there have been a limited number of randomized
controlled trials analyzing the effectiveness of various
psychosocial interventions in CHR, such as cognitive behavioral
therapy (CBT), family focused therapy (FFT), or cognitive
remediation (5, 22–24). Meta-analyses of psychosocial
treatment effects on attenuated psychotic symptoms and
negative symptoms yielded no statistically significant treatment
effects for any intervention examined, although there were trends
(p = .07) for CBT, FFT, and cognitive remediation (25, 26).
Importantly, the existing RCTs use “transition to psychosis” as
the primary outcome measure of treatment efficacy. However, the
goal of psychosocial treatments may be reframed as improving
cognitive, social, and functional impairments that are associated
with poor prognosis in CHR, rather than preventing conversion
to psychosis. In other words, for some individuals, “transition to
psychosis” may be inevitable, but the degree of impairment
associated with psychosis can be reduced if these individuals
are provided skills to better cope with the cognitive and functional
deficits associated with CHR.
In fact, cognitive deficits are a key determinant of functional
outcomes in people with schizophrenia (27, 28) as well as
individuals meeting CHR criteria (29, 30), irrespective of later
development of a psychotic illness (15, 31, 32). Thus, there is a
critical need for early interventions to improve cognitive
impairment (and, therefore, everyday functioning) rather than
focusing solely on symptomatic remission. Cognitive
intervention trials (i.e., cognitive remediation or cognitive
training) in individuals meeting CHR or early psychosis
criteria remain limited and have produced mixed findings (33);
although improvements in cognitive outcomes have been noted
in some cognitive domains, these cognitive gains do not always
generalize to improvements in community functioning.
Although pro-cognitive interventions in pre- and early illness
stages appear promising, preliminary evidence suggests that a
compensatory strategy approach may best target areas of
cognition typically impaired in early psychosis (34).
Compensatory Cognitive Training (CCT; (35–37), a strategy-
based cognitive training approach, is one such psychosocial
intervention that may hold promise as an efficacious treatment
for CHR individuals. The most recent review and meta-analysis
of cognitive remediation studies (35) found the largest effect sizes
for compensatory strategy-based approaches in the context of
psychiatric rehabilitation. In addition to improvements inJanuary 2020 | Volume 10 | Article 951
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demonstrated a large effect size for negative symptoms (38, 39).
CCT strategies teach participants how to bypass their deficits and
directly address functional recovery through a focus on
application of appropriate cognitive strategies in the real world.
In essence, CCT provides an intervention that targets healthy
neural circuitry to compensate for damaged circuit elements, or
even protect this circuitry from future damage (40). The merits
of CCT also exist in its format; it is manualized, group-based,
low-tech, brief (38), and can easily be applied in the community
in English or Spanish, making it a practical intervention for
underserved populations.
Latino CHR individuals represent an underserved population
in the United States. Latinos have become the largest minority
group in the US (41); more than half (~54%) of California’s
elementary children are now of Latino origin (42). Despite the
rising population of Latinos, disparities in mental health care
continue to exist (43). Availability of and access to mental health
resources is also limited in Mexico, with the Instituto Nacional
de Neurología y Neurocirugía (INNN) serving as a local and
national reference institution for the evaluation of CHR and early
psychosis cases in Mexico City, a catchment area of over 20
million people. Latinos with CHR also present unique clinical
challenges, presenting greater educational needs and exhibiting
more severe negative symptoms predictive of conversion to
psychosis (44).
Considering negative symptom severity is a predictor of long-
term poor psychosocial functioning in schizophrenia (45) and
CHR patients (30), and the lack of efficacy of any psychosocial or
pharmacologic interventions in improving this symptom
dimension in CHR patients (26), CCT’s demonstrated efficacy
for improving both cognition and negative symptom severity
makes it a suitable intervention to evaluate within Latino CHR
youth. As such, the aim of this paper is to describe the
development and implementation of an ongoing pilot
randomized controlled trial investigating the efficacy of CCT,
as compared to recreational therapy (RT), for CHR Latino
participants in both the United States and Mexico. We
hypothesize that, in comparison to those receiving RT,
participants receiving CCT will show significant improvements
in neurocognitive performance and functional capacity (co-
primary outcomes) and self-rated functioning and clinical
symptoms (secondary outcomes).DESIGN AND METHODS
We are currently conducting a dual center (University of
California, San Diego [UCSD] and INNN) randomized
controlled trial of CCT compared to RT for CHR Latino youth
in the United States and Mexico. The study is registered as a
cl in ica l tr ia l (Cl inical Tria ls regis trat ion number:
NCT02245607). Baseline assessment confirms CHR criteria,
and participants are subsequently randomized in groups to
receive group-based CCT or RT. Study procedures were
approved by the University of California, San DiegoFrontiers in Psychiatry | www.frontiersin.org 3Institutional Review Board and by the Ethics and Scientific
Committees of INNN.
Participants
Projected enrollment is 120 CHR Latino youth (60 participants
per site). In San Diego, participants are referred to the study by
community health practitioners in San Diego who serve the
Latino community, public schools in high Latino districts,
County Mental Health, and the National Alliance on Mental
Illness. In Mexico City, participants are recruited via the
Neuropsychiatric Service, Early Psychosis Clinic, an advocacy
group (Asociación de Familiares y Amigos de Personas con
Esquizofrenia - AFAPE), and the Adolescent Study of
Neuropsychiatric Assessment and Imaging (PIENSA) Program
at INNN. Inclusion criteria are: 1) between the ages of 12 and 30;
2) meet CHR criteria per the Structured Interview for Prodromal
Syndromes (SIPS); and 3) be of Latino descent. Specific to the
Mexico City site, participants are eligible only if Spanish is their
preferred language. Exclusionary criteria are: 1) current or
lifetime psychotic disorder; 2) concomitant medical or
neurological illness; 3) brain injury with loss of consciousness
>30 min; 4) current substance abuse that interferes with group or
assessment procedures or is judged to be causing subsyndromal
psychotic symptoms (excluding nicotine); 5) IQ < 80; 6) high
suicidal risk; and 7) Axis I disorder or substance use that better
accounts for subsyndromal psychotic symptoms. Latino descent
was identified through participant/family self-report. Only
Spanish-speaking individuals were eligible for enrollment at
the INNN site to reduce confounding factors associated with
using two separate manuals presented in different languages for
groups at that site. Psychotropic medication is permitted,
including antipsychotics, antidepressants, and mood stabilizers.
All cases are discussed in a weekly conference call between sites
to reach consensus on inclusion/exclusion criteria and symptom
and functional ratings. All participants over the age of 18 provide
written informed consent; minors provide assent with written
consent by a parent or legal guardian.
Treatment
Eligible participants are assigned to one of the two treatment
conditions: CCT and RT. Both treatments are manualized, 12-
week interventions. Via a randomization schedule developed by
the study statistician, all eligible participants are randomized in
groups (goal 4–6 per group) to receive 12 weeks of CCT or RT.
Moreover, participants’ age is factored in the randomization
process to ensure that each intervention group only includes
participants falling within a distinct age group (12–14, 15–17,
and 18–30). This guideline was determined through direct
communication with the National Institute of Mental Health
(NIMH), given NIMH’s concern for minors being co-enrolled
and randomized into the same group with legal-aged adults.
Compensatory Cognitive Training
CCT is delivered in accordance with the manual and has been
described extensively elsewhere (38). Briefly, participants in the
CCT group receive weekly 90-min group CCT sessions for 12
weeks, which involve education regarding targeted skill areas asJanuary 2020 | Volume 10 | Article 951
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memory, attention, learning/memory, and executive functioning.
The CCT strategies are presented in an interactive, game-like
format to maintain interest and reduce attrition. Homework
assignments are designed to encourage additional practice
outside treatment sessions. At the beginning of each session,
previous homework assignments are reviewed or completed in
vivo to ensure skill proficiency and execution. As the ongoing
study is a feasibility trial, minor age-related modifications were
made as necessary to ensure CCT was engaging and relevant
to the specific needs of young Latinos with CHR (e.g., using
Spanish names, focusing on school-related versus work-
related examples).
English and Spanish versions are used in the study and
employed based on the group’s preferred language. The
Spanish translation of the CCT manual (46), a collaborative
effort between investigators at UCSD, INNN, and the University
of Deusto, Bilbao, is applicable in both Spain and Latin America
(translation performed by natives of Spain and Mexico).
Translation back to English by translators unfamiliar with the
manual was very successful and the final Spanish CCT manual
required very little modification.
Recreational Therapy
RT was selected as a robust control condition, a group therapy
intervention that provides the same frequency and amount of
therapist and other group member contact as CCT, but does not
provide any cognitive training. Participants assigned to the RT
sessions participate in different recreational activities targeting
their popular culture awareness, art, and physical activities. The
12 sessions of RT, also broken down into modules, consist of
discussions on topics such as music, current events, art, and
health. Reference materials were selected from current media
(newspapers, magazines, and internet). Practice of RT skills is
encouraged outside of session, but no formal homework
assignments are given. At the beginning of each session,
previous week’s concepts are reviewed. The purpose of these
sessions is to provide participants with access to information that
would encourage social interactions and the addition of physical
activity to their daily routine.
Assessments
Following enrollment/randomization, participants complete
assessments at baseline, mid-intervention (4 weeks, 8 weeks),
post-intervention (12 weeks) and 3-month follow-up, conducted
by clinical raters and research assistants blind to group
assignment (see Table 1 for the Assessment Overview).
Participants are compensated for their time per assessment and
at each group session to offset the cost of transportation.
Following baseline assessment, participants receive 12 weeks of
their assigned intervention, delivered by bachelor’s level or above
therapists at each site. Therapists administer both treatments in
an alternating schedule to avoid therapist effects in the design.
The primary outcome measures are neurocognition and
functional capacity, as assessed by the measures detailed below.
Furthermore, secondary outcomes measures will be used toFrontiers in Psychiatry | www.frontiersin.org 4examine change in clinical symptoms and self-reported
functioning in response to CCT versus RT.
Cognitive and Functional Assessment
Premorbid intellectual functioning is assessed via the Wechsler
Adult Intelligence Scale (WAIS), Block Design and Vocabulary
subtests. Participants are administered an expanded MATRICS
(Measurement and Treatment Research in Cognition in
Schizophrenia) Consensus Cognitive Battery (MCCB) in
English or Spanish (47). The MCCB has excellent qualities,
including psychometric properties for longitudinal studies,
utility as a repeated measure, relevance to functional outcome,
brevity, ease of use, and participant tolerability. These
tests are administered according to published standardized
procedures. As part of collaborative studies, the UCSD team
has traveled to Mexico City and standardized administration
of the neuropsychological battery. The battery includes
the following domains: 1) Estimated IQ: Wechsler Adult
Intelligence Scale Vocabulary and Block Design, 2) Learning
& Memory: Hopkins Verbal Learning Test, Brief Visual Memory
Test–R, 3) Processing Speed: Brief Assessment of Cognition in
Schizophrenia: Symbol Coding, Category Fluency, Trail Making
Part A, 4) Attention/Vigilance: Continuous Performance
Task Identical Pairs, 5) Working Memory: WMS III Spatial
Span, University of Maryland Letter-Number Span, and
6) Executive Functioning: Neuropsychological Assessment
Battery Mazes, Wisconsin Card Sorting Test. A Global
Cognitive Index will combine z scores of all cognitive domains
per established methods (8). The University of California, San
Diego Performance-Based Skills Assessment-Brief (UPSA-Brief)
was selected to measure performance-based functional capacity
(48), along with UPSA-Child and Adolescent version for
adolescents. The Specific Levels of Functioning (SLOF) scale is
used as a self-reported functioning measure because of its
concordance with objective ability measures (49). In addition,
the modified Global Assessment of Functioning (50) and the
Social Adjustment Scale (51) are administered.Clinical Assessment
CHR is assessed using the SIPS, with symptom ratings measured
via the Scale of Prodromal Symptoms (SOPS) (1). To assure
reliable diagnostic and clinical assessment across sites, a
consensus diagnosis procedure was developed, including
weekly clinical calls with certified Ph.D. or M.D. raters, all of
whom were trained by Yale developers of the SIPS. Participants
are also administered Structured Clinical Interview for DSM-IV
Axis I Disorders (SCID) (52). Current and past psychosocial
treatment, medication and hospitalization data are collected for
all participants. Finally, the Alcohol/Drug Use Scale (AUS/DUS)
is administered to measure current substance use (53).
During the final group session, all participants are given an
exit interview in which they complete a small survey examining
overall satisfaction with the intervention. Participants are asked
to provide self-rated impressions of improvement in
concentration, memory, attention, as well as conversational
and task vigilance. These impressions are rated on a scale of 1January 2020 | Volume 10 | Article 951
Mahmood et al. CCT for CHR Latino Youth(not at all helpful) to 10 (very helpful) referring to whether
participants found the skills taught during group to be helpful in
improving each respective domain of cognition. Participants are
also given the opportunity to provide qualitative feedback
regarding additional topics to be covered, topics to be
removed, and feedback regarding difficulty attending group
sessions, as well as any other suggestions to improve groups.
Design Considerations
Focusing on compensatory and environmental strategies, rather
than drill and practice computer exercises, is consistent with
empirical focus on improving functional skills among patients
with schizophrenia (54, 55). In addition to attention, learning
and memory, and executive functioning, the CCT intervention
targets prospective memory ability (i.e., the ability to remember
to do things in the future, such as complete homework
assignments or attend a doctor’s appointment). These CCT-Frontiers in Psychiatry | www.frontiersin.org 5targeted areas of cognition represent potentially modifiable
cognitive domains with relevance for psychosocial functioning
(27, 56, 57). Moreover, these domains represent areas of
cognition also affected in the prodromal phase (9, 58) and
predictive of later conversion to psychosis, thereby serving as
key initial treatment targets. Prevention of further deterioration
and preservation of cognitive abilities may be vital first steps to
increase the effectiveness of other psychosocial treatments.
Another strength of CCT is its exploitation of stronger
cognitive functions in schizophrenia, such as imagery (59) and
habit learning (60, 61), to bolster impaired abilities; for example,
forming new habits in attention and problem-solving can lead to
gains in performance efficiency via automatic processing and
decreased cognitive demands. Increasing individuals’ ability to
remember appointments, sustain attention, encode important
concepts, and think flexibly may well improve the success of
concomitant treatments.TABLE 1 | Assessment Overview.
Time
(Hour : Min)
Baseline Week 4 Week 8 Week 12 Week 24
Clinical (Day 1) 2:30 X X X
Demographics :15 X X X
SCID-I 1:00 X X X
SIPS/SOPS 1:00 X X X X X
AUS/DUS :15 X X X X X
Functional (Day 1) 1:35 X X X
SAS-SR :15 X X X
GAF :05 X X X
SLoF :30 X X X
UPSA :45 X X X
Day 1 Total 4:05 X X X
Neurocognitive
Battery (Day 2)
2:15 X X X
General Intelligence
WAIS Vocabulary :15 X X X
WAIS Block Design :10 X X X
Verbal Learning
HVLT :05 X X X
BVMT :05 X X X
Processing Speed
BACS Symbol Coding :05 X X X
Category Fluency :05 X X X
Trails A :05 X X X
Attention/Vigilance
CPT-IP :10 X X X
Working Memory
WMS III Spatial Span :10 X X X
LNS :10 X X X
Executive Functioning
NAB Mazes :10 X X X
WCST :10 X X X
Day 2 Total 2:15 X X X
Exit Interview :30 X
Total Assessment Time (H:M) 6:20 1:15 1:15 6:50 6:20January 2020 | Volume 10 | AStructured Interview for Prodromal Syndromes (SIPS), Scale of Prodromal Symptoms (SOPS), Structured Clinical Interview for DSM-IV (SCID) Axis I, The Social Adjustment Scale – Self-
Report (SAS-SR), Global Assessment of Functioning (GAF), Specific Level of Functioning (SLoF), The UCSD Performance-Based Skills Assessment (UPSA), Wechsler Adult Intelligence
Scale (WAIS), Hopkins Verbal Learning Test (HVLT), Brief Visual Memory Test–R (BVMT), Brief Assessment of Cognition in Schizophrenia (BACS), Category Fluency, Trail Making Part A,
Continuous Performance Task Identical Pairs (CPT-IP), Wechsler Memory Scale (WMS), Univ. of Maryland Letter-Number Span (LNS), Neuropsychological Assessment Battery (NAB)
Mazes, Wisconsin Card Sorting Test (WCST).rticle 951
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Mental health providers at the bachelor’s level or above deliver
the treatment. Two San Diego site therapists, as well as one
investigator and one study therapist at the Mexico City site, were
formally trained on the CCT protocol by EWT at study
initiation. The 2-day training included an introduction to the
theoretical principles underpinning the treatment model, specific
instructions on implementing each of the twelve CCT sessions,
and review of RT sessions. Weekly individual supervision is
ongoing throughout the trial between the study therapists
and PIs.
Fidelity
Research recommendations by Perepletchikova and Kazdin (62)
were implemented to maximize treatment manual adherence
(e.g., use of checklists). All CCT and RT sessions are recorded to
monitor fidelity; sessions are rated using items from the
Cognitive Training Fidelity Scale (unpublished; available upon
request from the authors). Therapist compliance was defined as
90% adherence to the items on the weekly checklist; subthreshold
fidelity ratings will result in remedial training until these levels
are achieved. To reduce the risk of treatment contamination,
groups will be held at times and locations where subjects in
different groups will not have the opportunity to meet in a
waiting room. We will also ask subjects not to discuss their
treatment with other subjects until after completion of the
protocol. Monthly fidelity ratings will be fed back to therapists
during supervision to improve fidelity. RT sessions will also be
rated to ensure that RT groups do not receive training in
CCT skills.
Data Analysis
The purpose of this pilot RCT is to examine feasibility and
generate effect sizes to establish benchmarks for future studies,
not to complete an adequately powered efficacy study. Power
calculations based on Cohen method (63) and the method
provided by Hedeker et al. for the Random Regression Model
(64) indicated that with the proposed sample size, we will have a
minimum 80% power to detect a medium to large effect across
groups, consistent with the medium to large effects in
prior studies.
A linear mixed model, with post-hoc procedures if indicated,
will be used to analyze data in order to compare CCT versus RT
in Latino CHR subjects in the United States and Mexico (co-
primary outcomes: neurocognition [Global Cognitive Index and
individual domain scores] and functional capacity; secondary
outcomes: self-reported functioning and clinical symptom
severity). Feasibility data such as recruitment rate, consent rate,
reasons for not participating, reasons for dropping out,
participants’ satisfaction, and their suggestions to improve the
study will be tabulated and will be analyzed descriptively.
Furthermore, predictors (moderators) of response to CCT
versus RT, including age, baseline symptom severity,
neurocognition, and comorbidity, will be explored. Moderators
will be examined by building hierarchical linear models with
potential moderator variables (e.g., baseline symptoms,Frontiers in Psychiatry | www.frontiersin.org 6neurocognition, functioning, age, and comorbidity) included in
the model (65). The linear model to be used for both moderator
and mediator analyses will compare CCT versus RT treatment
groups. The independent variables are treatment group,
moderator, and the treatment-moderator interaction. An
interactive effect will mean that the effect of treatment on
individual subjects depends on their value of moderator.
Finally, mediators of functional outcomes, including
improvement in cognition and symptom severity, will be
explored. Mediation analyses will use a similar linear mixed
models approach. Two conditions must be met for mediation of
the treatment effect: 1) correlation between the mediator and
treatment; and 2) relationship between the mediator and outcome
(65). First, we will test the effect of treatment group and the group
× time interaction on the mediator (for example, improvement in
cognition), and we expect a statistically significant group × time
interaction. Second, we will test the effects of neurocognitive
change (change score from baseline to mid-treatment) and the
Global Cognitive Index change × group interaction on the
outcome (UPSA) in the model that includes group and time,
and we expect a statistically significant mediator × time or
mediator × group × time interaction. The Global Cognitive
Index change score from baseline to midway establishes
temporal precedence of the mediator. We will also explore
whether change in Global Cognitive Index and other variables
mediates change in the other outcome variables (e.g.,
functioning). Finally, we will explore the relationships between
specific measures (e.g., specific symptom factors) and functioning,
number of sessions attended, as well as relationships between
change in one domain and change in another (e.g., between
change in symptoms, neurocognition, with change in
functioning), when appropriate.DISCUSSION
Developing psychosocial interventions to improve cognitive and
functional outcomes in CHR participants is a research priority.
In addition, the development of treatments that can be feasibly
and acceptably delivered to diverse and underserved populations
is greatly needed. CCT is a psychosocial intervention with
demonstrated efficacy in first episode and chronic
schizophrenia (35, 36), but remains to be evaluated in pre-
illness phases.
Studies of cognitive training interventions in pre-psychotic
illness remain limited. One study has demonstrated acceptability
and feasibility of a compensatory-based approach (Cognitive
Adaptive Training) in early illness phase (34); however, the small
sample size (n = 5), individual format, and lengthy duration
undermined its widespread application in real-world settings.
Although preliminary evidence suggests computerized drill-and-
practice as a feasible intervention with potential cognitive
benefits for CHR (66), controlled studies are not yet published.
The availability of CCT as a freely accessible, brief, manualized,
group-based intervention provides a low-cost, scalable, and
clinically relevant treatment with promise for widespreadJanuary 2020 | Volume 10 | Article 951
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its availability in both English and Spanish and because it can be
delivered by bachelor and master’s level clinicians. Furthermore,
sample diversity in the ongoing trial is enhanced via recruitment
from both US and Mexico, demonstrating attention to
burgeoning national and international preventive efforts in
psychosis research.
Several aspects of our study design could affect feasibility of
participant recruitment and retention across sites, as well as
generalizability. First, due to the nature of our established clinical
services, groups are facilitated outpatient psychiatric service
settings rather than primary care. In the United States,
minority/immigrant individuals may be more likely to engage
in mental health treatment through primary care settings as
compared to specialty mental health settings (67, 68). Second, to
increase socialization, we opted to offer clinic-based groups
rather than home-based care. Some participants who prefer
individual treatment or who cannot easily access transportation
may be less likely to participate. The willingness of parents of
minors to take time off work to facilitate their children’s
participation may also affect participation and retention. As such,
future investigations may consider CCT delivery in real-world
settings, or a telemedicine approach. To our knowledge, no
studies to date have sought to investigate the feasibility of remote
treatment delivery methods for CHR populations. Third, group
randomization and stratification methods require that children,
adolescents, and adults be separated into different groups. Thus,
additional challenges are introduced in recruiting a sufficient
number of individuals within the same age cohort to begin a
group of at least 4–6 individuals. Finally, our results may not
generalize to non-Latino CHR youth. Research on Latino youth
indicate that prevalence rates of depressive symptomatology and
alcohol use are significantly higher in Latino youth and these
populations have inadequate access to mental health services (69).
Thus, in addition to the considerations above, it is possible that
CCT is differentially effective for this population given known
mental health co-morbidities as well as access barriers.
Despite these potential limitations in study design, the
introduction of cognitive training techniques at the INNN, the
primary psychosis referral center in a city of over 20 million, is
significant in that very few psychosocial treatments for
schizophrenia are administered in Mexico. This work will
clearly influence the treatment of psychotic illness in LatinFrontiers in Psychiatry | www.frontiersin.org 7America and the United States. This study will provide
valuable information regarding the feasibility and efficacy of
CCT to treat CHR Latino youth. UCSD’s association with the
North American Prodrome Longitudinal Studies (NAPLS)
Consortium and the International Prodromal Research
Network offers a platform for a larger scale treatment study
should the proposed treatment prove promising. If found to
be efficacious, CCT-associated improvements in cognitive
and functional performance may well enhance success of
concomitant treatments.ETHICS STATEMENT
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